Article citationsMore>>

M. J. Ellis, V. J. Suman, J. Hoog, et al., “Randomized Phase II Neoadjuvant Comparison between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype— ACOSOG Z1031,” Journal of Clinical Oncology, Vol. 29, No. 17, 2011, pp. 2342-2349. http://dx.doi.org/10.1200/JCO.2010.31.6950

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top